Minerva Neurosciences (NERV) Current Deferred Revenue (2014 - 2016)

Minerva Neurosciences has reported Current Deferred Revenue for 3 years, with the latest figure at $3.5 million in Q3 2016.

• For the quarter ending Q3 2016, Current Deferred Revenue changed N/A year-over-year to $3.5 million; the trailing twelve-month figure through Sep 2016 stood at $3.5 million (changed N/A YoY), and the FY2014 full-year result was $7226.0, changed N/A from the prior year.
• Current Deferred Revenue for Q3 2016 stood at $3.5 million, up from $8237.0 in the prior quarter.
• The five-year high for Current Deferred Revenue was $3.5 million in Q3 2016, with the low at $7226.0 in Q4 2014.
• Historically, Current Deferred Revenue has averaged $1.2 million across 3 years, with a median of $8237.0 in 2015.